Systematic evaluation on nimodipine combined with cerebrospinal fluid exchange in treating subarachnoid hemorrhage
10.3969/j.issn.1671-8348.2013.25.010
- VernacularTitle:尼莫地平联合脑脊液置换治疗蛛网膜下腔出血的系统评价
- Author:
Xia FENG
;
Changqing ZHOU
;
Xiao HOU
;
Yi ZHANG
- Publication Type:Journal Article
- Keywords:
subarachnoid hemorrhage;
nimodipine;
cerebrospinal fluid exchange
- From:
Chongqing Medicine
2013;(25):2977-2980
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy of nimodipine combined with cerebrospinal fluid exchange in treating subarachnoid hemorrhage (SAH) .Methods The electronic databases and manual retrieval ,and the meta-analytic method were used to conduct the systematic evaluation on the efficacies of nimodipine combined with cerebrospinal fluid exchange versus routine internal medicine therapy for treating SAH in all the included randomized controlled trials (RCTs) .Results 16 RCTs(n=1 076) were included .The methodological quality of all included trials was poor .Compared with the routine internal medicine therapy ,nimodipine combined with cerebrospinal fluid exchange could reduce the occurrence of cerebral vasospasm (RR 0 .33 ,95% CI 0 .25-0 .43 ,P<0 .01) ,hy-drocephalus(RR 0 .28 ,95% CI 0 .18-0 .44 ,P<0 .01) and mortality after SAH (RR 0 .41 ,95% CI 0 .24-0 .70 ,P=0 .001) ,while no difference was found in the occurrence of re-bleeding between two groups(RR 0 .89 ,95% CI 0 .53-1 .50 ,P=0 .67) .Conclusion The current clinical research evidences demonstrate that the combination of nimodipine and cerebrospinal fluid exchange can re-duce the occurrence of cerebral vasospasm and hydrocephalus ,decrease the mortality after SAH But further well-designed multi-center RCTs with larger sample should be carried out to confirm our findings due to the influence of the poor quality of included tri-als .
